ALEXANDRIA, Va., Feb. 11 -- United States Patent no. 12,544,363, issued on Feb. 10, was assigned to Emory Univeristy (Atlanta).
"N-methyl-D-aspartic acid receptor modulators" was invented by Dennis Liotta (Atlanta), Stephen F. Traynelis (Atlanta), David Menaldino (Atlanta) and Matthew Epplin (Atlanta).
According to the abstract* released by the U.S. Patent & Trademark Office: "A series of subunit selective allosteric modulators of NMDA receptor function according to Formula (I) is provided herein. Also provided is a method of treating neurological disorders such as Alzheimer's disease Parkinson's disease, schizophrenia, depression, stroke, psychosis and the like using compounds of Formula (I), optionally in combination with one or more fu...